Hormonal contraception and the risk of HIV acquisition among women in South Africa

AIDS

Volumn 26, Issue 4, 2012, Pages 497-504

  Morrison, Charles S ^a   Skoler Karpoff, Stephanie ^b,c   Kwok, Cynthia ^a   Chen, Pai Lien ^a   Van De Wijgert, Janneke ^c,d   Gehret Plagianos, Marlena ^c   Patel, Smruti ^e   Ahmed, Khatija ^f   Ramjee, Gita ^g   Friedland, Barbara ^c   Lahteenmaki, Pekka ^c,h  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c POPULATION COUNCIL   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^g SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Africa; depo provera; heterosexual transmission; HIV acquisition; hormonal contraception; oral contraceptives; women

Indexed keywords

CARRAGEENAN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; FEMALE; HAZARD RATIO; HIV TEST; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INJECTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT PARTICIPATION; PELVIC EXAMINATION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEMI STRUCTURED INTERVIEW; SEROLOGY; SEXUAL BEHAVIOR; SOUTH AFRICA;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; NORETHINDRONE; ODDS RATIO; PREGNANCY; PROPORTIONAL HAZARDS MODELS; SEXUAL BEHAVIOR; SOUTH AFRICA; VAGINAL CREAMS, FOAMS, AND JELLIES; YOUNG ADULT;

EID: 84857057111     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32834fa13d     Document Type: Article

References (22)

1. Population Reference Bureau. Family Planning Worldwide 2008 Data Sheet. Washington, DC: Population Reference Bureau; 2008.
2. World Contraceptive Use 2003. New York, New York: United Nations, Department of Economic and Social Affairs Population Division; 2003.
3. South Africa Demographic and Health Survey 2003. Pretoria, South Africa: Department of Health, Medical Research Council, OrcMacro; 2007.
4. Morrison CS, Richardson BA, Mmiro F, Chipato T, Celentano DD, Luoto J, et al. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95. (Pubitemid 44912541)
5. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007; 21:1771-1777. (Pubitemid 47237565)
6. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2:1084-1089. (Pubitemid 26338626)
7. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010; 24:1778-1781.
8. Morrison CS, Turner AN, Jones LB. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009; 23:263-284.
9. Trunova N, Tsai L, Tung S, Schneider E, Harouse J, Gettie A, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 2006; 352:169-177. (Pubitemid 44142685)
10. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, doubleblind, placebo-controlled trial. Lancet 2008; 372:1977-1987.
11. Cele N, Palanee T, Myeni N, Mnyandu N, Langa Z, Shange E, et al. Impact of provision of hormonal contraception on pregnancy incidence in women enrolled in the Phase 3 Carraguard clinical trial at three sites in South Africa. New Delhi, India: Poster presentation at Microbicides Conference; 2008.
12. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-560. (Pubitemid 30660034)
13. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the joint causal effect of nonrandomized treatments. J Am Stat Assoc 2001; 96:440-448.
14. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84:1074-1078.
15. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2011. [Epub ahead of print]
16. Kleinschmidt I, Rees H, Delany S, Smith D, Dinat N, Nkala B, et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007; 75:461-467. (Pubitemid 46764303)
17. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174. (Pubitemid 47061592)
18. Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocrine Rev 2010; 31: 79-97.
19. Sterne JA, Hernan MA, Ledergerber B, Tilling K, Weber R, Sendi P, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366:378-384. (Pubitemid 41073955)
20. Brotman RM, Klebanoff MA, Nansel TR, Andrews WW, Schwebke JR, Zhang J, et al. A longitudinal study of vaginal douching and bacterial vaginosis-a marginal structural modeling analysis. Am J Epidemiol 2008; 168:188-196. (Pubitemid 351951592)
21. Palella FJ Jr, Armon C, Buchacz K, Cole SR, Chmiel JS, Novak RM, et al. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med 2009; 151:73-84.
22. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11:561-570. (Pubitemid 30660035)